StreetInsider.com News Articles

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

The Johnson & Johnson, Pacira BioSciences and Orthofix executive takes charge of commercial execution as adoption of Canopus by eXeX accelerates across hospital systems in the United States and United Kingdom, and as eXeX launches Canopus Command, the first portal to give hospital leadership a live operational view into step-by-step execution of every surgical case.

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

Tue, 21 Jul 2026 09:00:00 -0400

ORLANDO, Fla. and LONDON, July 21, 2026 /PRNewswire/ -- eXeX, the global Surgery Intelligence company, today announced the appointment of Max Reinhardt as President, Healthcare. Reinhardt, who

Orthofix to Participate in Upcoming Investor Conferences

Mon, 20 Jul 2026 07:00:00 -0400

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Orthofix will participate in the following investor conferences:

Needham Virtual MedTech & Diagnostics 1x1 Conference - Virtual, August 10, 2026, 1x1 Meetings
Canaccord Genuity’s 46th Annual Growth Conference - Boston, August 12, 2026, Fireside Chat Time: 9:30 am Eastern Time

Interested parties can access the live and archived webcast of the Canaccord Genuity fireside chat in the “Events & Presentations” section of the Orthofix Investor Relations Website at ir.orthofix.com.

Internet Posting of Information

Orthofix regularly shares important

Orthofix to Participate in Upcoming Investor Conferences

Mon, 20 Jul 2026 07:00:00 -0400

Needham Virtual MedTech & Diagnostics 1x1 Conference - Virtual, August 10, 2026, 1x1 Meetings
Canaccord Genuity’s 46th Annual Growth Conference - Boston, August 12, 2026, Fireside Chat Time: 9:30 am Eastern Time

Internet Posting of Information

Orthofix regularly shares important

Orthofix to Participate in Upcoming Investor Conferences

Mon, 20 Jul 2026 07:00:00 -0400

Needham Virtual MedTech & Diagnostics 1x1 Conference - Virtual, August 10, 2026, 1x1 Meetings
Canaccord Genuity’s 46th Annual Growth Conference - Boston, August 12, 2026, Fireside Chat Time: 9:30 am Eastern Time

Internet Posting of Information

Orthofix regularly shares important

Orthofix to Participate in Upcoming Investor Conferences

Mon, 20 Jul 2026 07:00:00 -0400

Needham Virtual MedTech & Diagnostics 1x1 Conference - Virtual, August 10, 2026, 1x1 Meetings
Canaccord Genuity’s 46th Annual Growth Conference - Boston, August 12, 2026, Fireside Chat Time: 9:30 am Eastern Time

Internet Posting of Information

Orthofix regularly shares important

Orthofix to Report Second Quarter 2026 Financial Results

Wed, 15 Jul 2026 07:00:00 -0400

Company to Host Conference Call on Wednesday, August 5, 2026, at 8:30 am Eastern Time

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2026 financial results on Wednesday, August 5, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day.

Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the conference ID

Orthofix to Report Second Quarter 2026 Financial Results

Wed, 15 Jul 2026 07:00:00 -0400

Company to Host Conference Call on Wednesday, August 5, 2026, at 8:30 am Eastern Time

Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the conference ID

Orthofix to Report Second Quarter 2026 Financial Results

Wed, 15 Jul 2026 07:00:00 -0400

Company to Host Conference Call on Wednesday, August 5, 2026, at 8:30 am Eastern Time

Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the conference ID

Orthofix to Report Second Quarter 2026 Financial Results

Wed, 15 Jul 2026 07:00:00 -0400

Company to Host Conference Call on Wednesday, August 5, 2026, at 8:30 am Eastern Time

Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the conference ID

Canaccord Reiterates Buy Rating on Orthofix Medical (OFIX)

Mon, 06 Jul 2026 11:06:26 -0400

Canaccord analyst Caitlin Burrows reiterated a Buy rating and $18.00 price target on Orthofix Medical (NASDAQ: OFIX).

The analyst commented: "Thursday afternoon, OFIX announced that CMS has reversed the reimbursement changes previously implemented following the FDA's April 2026 reclassification of non-invasive bone growth stimulators (BGS) from Class III devices to Class II. As a reminder, in May CMS had revised certain billing requirements and Medicare fee schedule treatments for products billed under HCPCS codes E0747 (Fracture), E0748 (Spine), and E0760 (Ultrasound), leading OFIX to estimate ~10% decline in average Medicare reimbursement across its entire bone growth stimulation portfolio beginning May 18,

Orthofix Medical stock surges on Medicare reimbursement reversal

Mon, 06 Jul 2026 10:11:33 -0400

Investing.com -- Orthofix Medical Inc. shares jumped 15% Monday following news that Medicare reversed recent changes to reimbursement rates for non-invasive bone growth stimulators.

The Centers for Medicare & Medicaid Services on July 1, 2026, issued revised guidance withdrawing modifications to billing requirements and Medicare fee schedule treatment for non-invasive bone growth stimulators. The devices are billed under HCPCS codes E0747, E0748 and E0760.

The reversal came after CMS had modified billing requirements in May following the U.S. Food and Drug Administration’s reclassification of non-invasive bone growth stimulators from Class III to Class II devices on April 16, 2026. Those changes had

Form 8-K Orthofix Medical Inc. For: Jul 01

Thu, 02 Jul 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260702/26727375.html

Form 8-K Orthofix Medical Inc. For: Jul 01

Thu, 02 Jul 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260702/26727375.html

Form 4 Orthofix Medical Inc. For: Jun 18 Filed by: McPherron Aviva

Mon, 22 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260622/26673275.html